• 11813 Citations
  • 52 h-Index
1989 …2019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesco Perrone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

1 Citation (Scopus)

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., Jan 1 2019, In : European Journal of Cancer.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., 2019, In : European Journal of Cancer.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival
Biological Factors
Antineoplastic Agents
clinical trials
Clinical Trials
Costs and Cost Analysis

Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: A protocol

Riva, S., Bryce, J., De Lorenzo, F., Del Campo, L., Di Maio, M., Efficace, F., Frontini, L., Giannarelli, D., Gitto, L., Iannelli, E., Jommi, C., Montesarchio, V., Traclò, F., Vaccaro, C. M., Gallo, C. & Perrone, F., Sep 1 2019, In : BMJ Open. 9, 9, e031485.

Research output: Contribution to journalArticle

Italy
Bankruptcy
Neoplasms
Quality of Life
Universal Coverage

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

Morabito, A., Piccirillo, M. C., Maione, P., Luciani, A., Cavanna, L., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Morgillo, F., Burgio, M. A., Ferrara, D., Rosetti, F., Bianco, R., Artioli, F., Cortinovis, D., Gebbia, V., Fregoni, V., Mencoboni, M., Sandomenico, C. & 10 others, Rossi, A., Montanino, A., Manzo, A., Rocco, G., Arenare, L., Daniele, G., Signoriello, S., Gallo, C., Perrone, F. & Gridelli, C., Jul 1 2019, In : Lung Cancer. 133, p. 62-68 7 p.

Research output: Contribution to journalArticle

Non-Small Cell Lung Carcinoma
Cisplatin
Quality of Life
Drug Therapy
Mouth